Price of Nucleic Acids in India Fluctuates over 2022, Now at $35.9 per Kg

India Nucleic Acids Import Price in November 2022

In November 2022, the nucleic acids price amounted to $35.9 per kg (CIF, India), flattening at the previous month. Overall, the import price, however, continues to indicate slight growth. The most prominent rate of growth was recorded in March 2022 an increase of 178% against the previous month. As a result, import price attained the peak level of $78.4 per kg. From April 2022 to November 2022, the average import prices remained at a somewhat lower figure.

Prices varied noticeably by the country of origin: the country with the highest price was China ($28.5 per kg), while the price for Belgium ($2.4 per kg) was amongst the lowest.

From January 2022 to November 2022, the most notable rate of growth in terms of prices was attained by Belgium (+1.9%), while the prices for the other major suppliers experienced mixed trend patterns.

India Nucleic Acids Import Prices by Type

There were significant differences in the average prices amongst the major supplied products. In November 2022, the product with the highest price was other heterocyclic compounds, n.e.s. in October 2934, 2934.2 and 2934.3 ($1,536 per kg), while the price for heterocyclic compounds; containing a benzothiazole ring-system (whether or not hydrogenated), not further fused ($5.2 per kg) was amongst the lowest.

From January 2022 to November 2022, the most notable rate of growth in terms of prices was attained by other heterocyclic compounds, n.e.s. in October 2934, 2934.2 and 2934.3 (+15.5%), while the prices for the other products experienced more modest paces of growth.

India Nucleic Acids Imports

In November 2022, after three months of decline, there was growth in overseas purchases of nucleic acids and their salts, when their volume increased by 0.2% to 2.4K tons. In general, imports, however, saw a noticeable curtailment. The growth pace was the most rapid in April 2022 with an increase of 99% month-to-month. Over the period under review, imports reached the peak figure at 3.4K tons in January 2022; however, from February 2022 to November 2022, imports remained at a lower figure.

In value terms, nucleic acids imports dropped to $85M (IndexBox estimates) in November 2022. Over the period under review, imports, however, showed a noticeable setback. The most prominent rate of growth was recorded in October 2022 when imports increased by 64% against the previous month. Imports peaked at 120K tons in March 2022; however, from April 2022 to November 2022, imports stood at a somewhat lower figure.

India Nucleic Acids Imports by Type

In November 2022, nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 (1.6K tons) constituted the largest type of nucleic acids supplied to India, accounting for a 69% share of total imports. Moreover, nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 exceeded the figures recorded for the second-largest type, heterocyclic compounds; containing an unfused thiazole ring (whether or not hydrogenated) in the structure (502 tons), threefold. Heterocyclic compounds; containing a benzothiazole ring-system (whether or not hydrogenated), not further fused (239 tons) ranked third in terms of total imports with a 10% share.

From January 2022 to November 2022, the average monthly growth rate of the volume of import of nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 stood at -3.2%. With regard to the other supplied products, the following average monthly rates of growth were recorded: heterocyclic compounds; containing an unfused thiazole ring (whether or not hydrogenated) in the structure (+1.1% per month) and heterocyclic compounds; containing a benzothiazole ring-system (whether or not hydrogenated), not further fused (-9.8% per month).

In value terms, nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 ($79M) constituted the largest type of nucleic acids supplied to India, comprising 93% of total imports. The second position in the ranking was taken by heterocyclic compounds; containing an unfused thiazole ring (whether or not hydrogenated) in the structure ($5M), with a 5.8% share of total imports. It was followed by heterocyclic compounds; containing a benzothiazole ring-system (whether or not hydrogenated), not further fused, with a 1.5% share.

India Nucleic Acids Imports by Country

In November 2022, China (1.7K tons) constituted the largest supplier of nucleic acids to India, with a 73% share of total imports. Moreover, nucleic acids imports from China exceeded the figures recorded by the second-largest supplier, the Netherlands (442 tons), fourfold. The third position in this ranking was taken by Indonesia (90 tons), with a 3.8% share.

From January 2022 to November 2022, the average monthly rate of growth in terms of volume from China totaled -1.9%. The remaining supplying countries recorded the following average monthly rates of imports growth: the Netherlands (-0.0% per month) and Indonesia (+14.6% per month).

In value terms, China ($49M) constituted the largest supplier of nucleic acids to India, comprising 58% of total imports. The second position in the ranking was held by the Netherlands ($4.1M), with a 4.8% share of total imports. It was followed by Indonesia, with a 1.2% share.

From January 2022 to November 2022, the average monthly rate of growth in terms of value from China totaled -2.1%. The remaining supplying countries recorded the following average monthly rates of imports growth: the Netherlands (-0.9% per month) and Indonesia (+14.7% per month).

India's Nucleic Acid Industry Sees Slight Drop in Prices

India's nucleic acid industry faced significant fluctuations in 2022 with prices rising and falling unpredictably. However, the latest data shows that nucleic acid prices have dropped slightly. While the decline in price may seem small, it is a significant development for businesses operating in the sector.

The price drop can be attributed to various factors such as changes in demand, fluctuations in the global market, and potentially, increased competition. Despite the volatile year, the nucleic acid market remains robust and growth opportunities continue to abound.

Source: IndexBox Market Intelligence Platform